Suven Life Sciences Closes Trading Window for Insider Trading

Suven Life Sciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will remain shut until 48 hours after the declaration of the un-audited financial results for the quarter ended June 30, 2026. All designated individuals are prohibited from trading in the company's securities during this period. The date of the board meeting to approve these financial results will be communicated separately.